Related Experiment Video
Updated: Jun 27, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Association of high disease activity and serum IL-6 levels with the incidence of inflammatory major organ events in
Lisa Hirahara1, Yohei Kirino1, Yutaro Soejima1
1Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Monitoring Behçet disease (BD) activity using the BDCAF is crucial. Lower BDCAF scores correlate with fewer major organ events, and IL-6 may predict these events.
Area of Science:
- Rheumatology
- Immunology
- Clinical Medicine
Background:
- The relationship between Behçet disease (BD) activity and major organ events remains poorly understood.
- Inflammatory major organ events in BD affect the eyes, central nervous system, intestines, and vasculature.
Purpose of the Study:
- To investigate the association between Behçet Disease Current Activity Form (BDCAF) scores and the incidence of inflammatory major organ events in BD patients.
- To identify predictors of inflammatory major organ events through clustering analysis of clinical data, treatments, and serum cytokines.
Main Methods:
- Prospective registry study involving Japanese multicenter cohorts.
- Annual evaluation of BDCAF scores and monitoring of BD-related symptoms, including major organ events.
- Time-to-event analysis and unsupervised clustering of BDCAF, therapies, and serum cytokines.
Main Results:
- A total of 260 patients were analyzed, with a median BDCAF score of 2 at enrollment, indicating persistent disease activity.
- Patients with a BDCAF score of 0 showed significantly longer inflammatory major organ event-free survival compared to those with scores ≥1 (p=2.2 x 10-4).
- Clustering identified patients refractory to TNF inhibitors with high serum inflammatory cytokines, including IL-6, and increased major organ events.
Conclusions:
- Treatment strategies should focus on overall disease activity in Behçet disease.
- Monitoring residual serum IL-6 levels may aid in preventing inflammatory major organ events.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
The JAK-STAT Signaling Pathway
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

